The immunophenotype of ETP-ALL is defined as CD1a−, CD8−, CD5−/weak along with the expression of one or more myeloid or stem cell markers such as CD117, CD34, HLA-DR, CD13, CD33, CD11b, and CD65 [72]. The gene discussed is CD1A; the disease is acute lymphoblastic leukemia.